Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141015 |
| CAS No | NA |
| Mol.F. | C16H24ClN5O6S |
| Mol.Wt. | 449.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141016 |
| CAS No | NA |
| Mol.F. | C19H28ClN5O6S |
| Mol.Wt. | 490.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141017 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141018 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141019 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141020 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141021 |
| CAS No | 2476859-55-7 |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141022 |
| CAS No | NA |
| Mol.F. | C19H19N5O2 |
| Mol.Wt. | 349.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141023 |
| CAS No | NA |
| Mol.F. | C19H18N4O3 |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141024 |
| CAS No | NA |
| Mol.F. | C24H27N5O5 |
| Mol.Wt. | 465.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141025 |
| CAS No | NA |
| Mol.F. | C20H21ClN4O2 |
| Mol.Wt. | 384.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141026 |
| CAS No | NA |
| Mol.F. | C18H17ClN4O2 |
| Mol.Wt. | 356.8 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141027 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 : C9H10N4O4 |
| Mol.Wt. | 407.1 : 238.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141028 |
| CAS No | NA |
| Mol.F. | C10H13N9O3S |
| Mol.Wt. | 339.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141029 |
| CAS No | 73785-40-7 |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141030 |
| CAS No | NA |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |